Athira Pharma, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Athira Pharma, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2023.
  • Athira Pharma, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $3.21M, a 2.76% increase year-over-year.
  • Athira Pharma, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $10.6M, a 0.7% decline year-over-year.
  • Athira Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $10.6M, a 0.16% increase from 2022.
  • Athira Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $10.6M, a 129% increase from 2021.
  • Athira Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $4.62M, a 630% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $10.6M +$17K +0.16% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-22
2022 $10.6M +$5.98M +129% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-22
2021 $4.62M +$3.99M +630% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 $633K +$380K +150% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
2019 $253K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.